The Reliability and Prognosis of In-Hospital Diagnosis of Metabolic Syndrome in the Setting of Acute Myocardial Infarction
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (National Heart, Lung, and Blood Institute): Washington University School of Medicine SCCOR (P50HL077113-01)
- Genentech
- Genentech, Eli Lilly, Sanofi-Aventis, and Gilead Sciences
- Janssen (Johnson & Johnson) Genentech, F. Hoffmann-LaRoche, Pfizer, Daiichi Sankyo, NovoNordisk, Sanofi-Aventis, Regeneron, and Tethys Bioscience
- Boehringer-Ingelheim, Takeda, Orexigen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Daiichi Sankyo, and Merck Schering Plough
- GlaxoSmithKline
- American Heart Association, Genentech, Sanofi-Aventis, Gilead Sciences, Medtronic Minimed, Glumetrics
- Medtronic Minimed, Genentech, Gilead Sciences, F. Hoffmann-LaRoche, and Boehringer-Ingelheim
This publication has 11 references indexed in Scilit:
- Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.2013
- Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH)Circulation: Cardiovascular Quality and Outcomes, 2011
- Metabolic Syndrome Is Not Associated With Increased Mortality or Cardiovascular Risk in Nondiabetic Patients With a New Diagnosis of Coronary Artery DiseaseCirculation: Cardiovascular Quality and Outcomes, 2010
- Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trialHeart, 2007
- Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn StudyCirculation, 2005
- Increasing Prevalence of the Metabolic Syndrome Among U.S. AdultsDiabetes Care, 2004
- Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication ProgramAnnals of Internal Medicine, 2004
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenJAMA, 2002
- Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)The American Journal of Cardiology, 2001